SEVENRICH CAPITAL Announces the Group Participation of AHS Japan Corporation, Domestic Provider of Cranial Remolding Helmet 'Starband®' (World's #1 Market Share)
Key facts
- SEVENRICH CAPITAL Announces the Group Participation of AHS Japan Corporation, Domestic Provider of Cranial Remolding Helmet 'Starband®' (World's #1 Market Share)
- SEVENRICH CAPITAL, which supports corporate growth through M&A, announced that AHS Japan Corporation, the Japanese provider of the cranial remolding helmet 'Starband', has joined the SEVENRICH GROUP. They plan to strengthen marketing and expand treatment opportunities.
- Source: PR Times
- Date: March 30, 2026
Direct answer
SEVENRICH CAPITAL, which supports corporate growth through M&A, announced that AHS Japan Corporation, the Japanese provider of the cranial remolding helmet 'Starband', has joined the SEVENRICH GROUP. They plan to strengthen marketing and expand treatment opportunities.
- Citation
- SEVENRICH CAPITAL Announces the Group Participation of AHS Japan Corporation, Domestic Provider of Cranial Remolding Helmet 'Starband®' (World's #1 Market Share) (March 30, 2026), PR Times
- Source
- PR Times
- Date
- March 30, 2026
SEVENRICH CAPITAL, which supports corporate growth through M&A, announced that AHS Japan Corporation, the Japanese provider of the cranial remolding helmet 'Starband', has joined the SEVENRICH GROUP. They plan to strengthen marketing and expand treatment opportunities.
📋 Article Processing Timeline
- 📰 Published: March 30, 2026 at 20:00
- 🔍 Collected: March 30, 2026 at 22:56 (2h 56m after Published)
- 🤖 AI Analyzed: April 22, 2026 at 15:02 (544h 6m after Collected)
SEVENRICH CAPITAL Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Kenzo Hattori; hereinafter 'SEVENRICH CAPITAL'), which supports corporate growth through business succession and M&A, is pleased to announce that AHS Japan Corporation (Headquarters: Osaka-shi, Osaka; CEO: Hidetoshi Koga; hereinafter 'AHS Japan Corporation'), which provides the world's leading (*1) cranial remolding helmet 'Starband®' in Japan, has joined the SEVENRICH GROUP.
## Regarding AHS Japan Corporation's Participation in SEVENRICH GROUP
AHS Japan Corporation provides the cranial remolding helmet 'Starband®', developed by the US company Orthomerica, in Japan, striving to offer treatment opportunities for infant cranial deformation.
This active-type product is a fully custom-made cranial remolding helmet designed to fit the shape of each individual's head. It is introduced in over 37 countries worldwide (*2) and has been used by a cumulative total of over 600,000 infants (*3), making it the product with the No. 1 global market share (*1).
Since its introduction in Japan in 2007, it has been provided for over 18 years, boasting a cumulative track record of over 14,000 users (*4). Furthermore, the company has built a provision system through referrals from medical institutions, collaborating with over 45 university and core hospitals nationwide (*5).
SEVENRICH CAPITAL has decided to welcome AHS Japan Corporation into the SEVENRICH GROUP after evaluating the company's track record of collaboration with medical institutions, its achievements in the cranial remolding therapy field, and its room for growth.
## Business Growth Support by SEVENRICH CAPITAL
SEVENRICH CAPITAL supports companies in joining the SEVENRICH GROUP through business succession and M&A, and also provides hands-on support for corporate growth after participation.
By leveraging back-office functions such as accounting and tax affairs, as well as the group network, we will support the sustainable growth of companies.
With AHS Japan Corporation joining the group, we will promote the improvement of the business operation system, focusing on strengthening marketing and sales strategies, aiming for the company's further business growth.
We will strengthen the dissemination of information regarding the features and value of Starband®, such as its full custom-made design tailored to the individual head shape and growth of each child, and its abundant clinical track record, while enhancing the provision of information for parents.
Concurrently, we will advance the sophistication of our sales activities directed at pediatric clinics, university hospitals, postpartum care facilities, and others, aiming to build a system where information regarding treatment reaches people at the appropriate timing.
Through these efforts, we will work to expand awareness of cranial remolding therapy and create treatment opportunities.
## Regarding AHS Japan Corporation's Participation in SEVENRICH GROUP
AHS Japan Corporation provides the cranial remolding helmet 'Starband®', developed by the US company Orthomerica, in Japan, striving to offer treatment opportunities for infant cranial deformation.
This active-type product is a fully custom-made cranial remolding helmet designed to fit the shape of each individual's head. It is introduced in over 37 countries worldwide (*2) and has been used by a cumulative total of over 600,000 infants (*3), making it the product with the No. 1 global market share (*1).
Since its introduction in Japan in 2007, it has been provided for over 18 years, boasting a cumulative track record of over 14,000 users (*4). Furthermore, the company has built a provision system through referrals from medical institutions, collaborating with over 45 university and core hospitals nationwide (*5).
SEVENRICH CAPITAL has decided to welcome AHS Japan Corporation into the SEVENRICH GROUP after evaluating the company's track record of collaboration with medical institutions, its achievements in the cranial remolding therapy field, and its room for growth.
## Business Growth Support by SEVENRICH CAPITAL
SEVENRICH CAPITAL supports companies in joining the SEVENRICH GROUP through business succession and M&A, and also provides hands-on support for corporate growth after participation.
By leveraging back-office functions such as accounting and tax affairs, as well as the group network, we will support the sustainable growth of companies.
With AHS Japan Corporation joining the group, we will promote the improvement of the business operation system, focusing on strengthening marketing and sales strategies, aiming for the company's further business growth.
We will strengthen the dissemination of information regarding the features and value of Starband®, such as its full custom-made design tailored to the individual head shape and growth of each child, and its abundant clinical track record, while enhancing the provision of information for parents.
Concurrently, we will advance the sophistication of our sales activities directed at pediatric clinics, university hospitals, postpartum care facilities, and others, aiming to build a system where information regarding treatment reaches people at the appropriate timing.
Through these efforts, we will work to expand awareness of cranial remolding therapy and create treatment opportunities.
FAQ
What company has joined the SEVENRICH GROUP according to the announcement by SEVENRICH CAPITAL?
AHS Japan Corporation, a domestic provider of the cranial remolding helmet 'Starband®', has joined the SEVENRICH GROUP as announced by SEVENRICH CAPITAL.
What product does AHS Japan Corporation provide in Japan, and what is its global market position?
AHS Japan Corporation provides the cranial remolding helmet 'Starband®' in Japan, which holds the No. 1 global market share in its category.
Which U.S. company developed the 'Starband®' helmet distributed by AHS Japan Corporation?
The 'Starband®' helmet provided by AHS Japan Corporation was developed by the U.S. company Orthomerica.
How many infants in Japan have used the 'Starband®' helmet since its introduction in 2007?
Since its introduction in Japan in 2007, the 'Starband®' helmet has been used by over 14,000 infants cumulatively.
With how many university and core hospitals does AHS Japan Corporation collaborate nationwide for referrals?
AHS Japan Corporation collaborates with over 45 university and core hospitals across Japan for medical referrals.